[
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: Moderna Soars on Bird Flu Vaccine Potential",
    "summary": "The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest rate outlook.",
    "url": "https://finnhub.io/api/news?id=4b6d149571e22f8246e7af45b2b8f15720af6f31835feaa455fa91b023e0e3f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736286774,
      "headline": "S&P 500 Gains and Losses Today: Moderna Soars on Bird Flu Vaccine Potential",
      "id": 132310914,
      "image": "https://www.investopedia.com/thmb/XlzOVEhElastWy0hTFGKkmr5LLw=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2151784870-7b56f9a9411c42429a1f3aacf3c356e4.jpg",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest rate outlook.",
      "url": "https://finnhub.io/api/news?id=4b6d149571e22f8246e7af45b2b8f15720af6f31835feaa455fa91b023e0e3f2"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike",
    "summary": "Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.",
    "url": "https://finnhub.io/api/news?id=2a912aff353e614575e08703b5de5dd097a8f9538dc05efa70bbf8eae761f2e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736270606,
      "headline": "Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike",
      "id": 132304230,
      "image": "",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.",
      "url": "https://finnhub.io/api/news?id=2a912aff353e614575e08703b5de5dd097a8f9538dc05efa70bbf8eae761f2e7"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Up as Vaccine Makers Surge -- Health Care Roundup",
    "summary": "Health-care companies rose as a reported U.S. death from bird flu stoked fears of a new pandemic, boosting shares of vaccine makers. Moderna rose by more than 12%, while Novavax and CureVac also...",
    "url": "https://finnhub.io/api/news?id=e19754c09e86520ed9b0d374348640b876f96519f157b72516a6991052f7e5b4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736273714,
      "headline": "Health Care Up as Vaccine Makers Surge -- Health Care Roundup",
      "id": 132308418,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Health-care companies rose as a reported U.S. death from bird flu stoked fears of a new pandemic, boosting shares of vaccine makers. Moderna rose by more than 12%, while Novavax and CureVac also...",
      "url": "https://finnhub.io/api/news?id=e19754c09e86520ed9b0d374348640b876f96519f157b72516a6991052f7e5b4"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: 11.6% Increase After Bearish Options Sentiment Detected Days Before",
    "summary": "Moderna Soars Despite Bearish Options Bets",
    "url": "https://finnhub.io/api/news?id=dae0363e3f15997a0980d04b2568ae2b85a3bd40b6fba99490e22ff2c7db0a59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736272764,
      "headline": "Moderna: 11.6% Increase After Bearish Options Sentiment Detected Days Before",
      "id": 132310918,
      "image": "https://media.zenfs.com/en/us.finance.gurufocus/c4618e69192265b5b79b95e66c15fe9f",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna Soars Despite Bearish Options Bets",
      "url": "https://finnhub.io/api/news?id=dae0363e3f15997a0980d04b2568ae2b85a3bd40b6fba99490e22ff2c7db0a59"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Soars After First US Bird-Flu Death",
    "summary": "Moderna led S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.",
    "url": "https://finnhub.io/api/news?id=8b00faed813cb7913d8ffc289f36277590b3f320d0129310b8b292f59fa60d2f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736271311,
      "headline": "Moderna Stock Soars After First US Bird-Flu Death",
      "id": 132310920,
      "image": "https://www.investopedia.com/thmb/iMI1gr09nLwGGqE9Jo2TZ0jmIow=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2150746943-29953a04619c4fbe959376f97c6b6a10.jpg",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna led S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.",
      "url": "https://finnhub.io/api/news?id=8b00faed813cb7913d8ffc289f36277590b3f320d0129310b8b292f59fa60d2f"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death",
    "summary": "The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.",
    "url": "https://finnhub.io/api/news?id=abbde67330758bad4adee5c3d24e75bcc47013f4c7b2c6acea94c0f903118fc9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736254740,
      "headline": "Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death",
      "id": 132301064,
      "image": "https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.",
      "url": "https://finnhub.io/api/news?id=abbde67330758bad4adee5c3d24e75bcc47013f4c7b2c6acea94c0f903118fc9"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: Tesla, Moderna, Ulta Beauty, and More",
    "summary": "U.S. equities were mostly lower at midday as new concerns about inflation dragged down the tech sector.",
    "url": "https://finnhub.io/api/news?id=0521009ec4614eb5b6e347d431a1d08d291588256087f1b6c6d9017a6a3459fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736268464,
      "headline": "Top Stock Movers Now: Tesla, Moderna, Ulta Beauty, and More",
      "id": 132310924,
      "image": "https://www.investopedia.com/thmb/GVbGo7TRQzD36laiYpZVQlW9G_w=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2192201816-0ff17948cc784ba983e3922a9c4fc312.jpg",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "U.S. equities were mostly lower at midday as new concerns about inflation dragged down the tech sector.",
      "url": "https://finnhub.io/api/news?id=0521009ec4614eb5b6e347d431a1d08d291588256087f1b6c6d9017a6a3459fc"
    }
  },
  {
    "ts": null,
    "headline": "Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand",
    "summary": "Moderna leads vaccine rally amid rising respiratory infections, spurring investment in COVID-19, flu, and RSV solutions.",
    "url": "https://finnhub.io/api/news?id=9f8dd361055bf4d2fa868187ff77861ae36345f652a6673c0f9e8501fa86eea9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736267193,
      "headline": "Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand",
      "id": 132302354,
      "image": "https://media.zenfs.com/en/us.finance.gurufocus/c4618e69192265b5b79b95e66c15fe9f",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna leads vaccine rally amid rising respiratory infections, spurring investment in COVID-19, flu, and RSV solutions.",
      "url": "https://finnhub.io/api/news?id=9f8dd361055bf4d2fa868187ff77861ae36345f652a6673c0f9e8501fa86eea9"
    }
  },
  {
    "ts": null,
    "headline": "Why Vaccine Stocks, Lucid (LCID) Are Rallying",
    "summary": "Vaccine stocks and EV maker Lucid Technologies (LCID) are among today’s biggest winners today. Vaccine makers, including Moderna (MRNA), Novavax (NVAX), and BioNTech (BNTX), are rallying after the first U.S. death from bird flu was announced yesterday. Meanwhile, Lucid’s shares are climbing for a second straight day after the EV company reported higher-than-expected fourth-quarter deliveries […]",
    "url": "https://finnhub.io/api/news?id=b3dc4a0d6a00dd6c5cf48287643c3c405c91723df0c48cc0cc8d00facd049938",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736265051,
      "headline": "Why Vaccine Stocks, Lucid (LCID) Are Rallying",
      "id": 132302659,
      "image": "https://s.yimg.com/ny/api/res/1.2/qu0JoboCcI4gBXmIH5Cb9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/7fd433bbbf97652adb6c78f1a91c40fe",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Vaccine stocks and EV maker Lucid Technologies (LCID) are among today’s biggest winners today. Vaccine makers, including Moderna (MRNA), Novavax (NVAX), and BioNTech (BNTX), are rallying after the first U.S. death from bird flu was announced yesterday. Meanwhile, Lucid’s shares are climbing for a second straight day after the EV company reported higher-than-expected fourth-quarter deliveries […]",
      "url": "https://finnhub.io/api/news?id=b3dc4a0d6a00dd6c5cf48287643c3c405c91723df0c48cc0cc8d00facd049938"
    }
  },
  {
    "ts": null,
    "headline": "U.S. Bird Flu Death Stokes Fears of Another Pandemic. What History Can Teach Us.",
    "summary": "U.S. Bird Flu Death Stokes Fears of Another Pandemic. What History Can Teach Us.",
    "url": "https://finnhub.io/api/news?id=beb591990a9d1c4cc9943b7a198492d32cd9d1cefe24a6de7b878113ff645fa6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736261640,
      "headline": "U.S. Bird Flu Death Stokes Fears of Another Pandemic. What History Can Teach Us.",
      "id": 132537823,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "U.S. Bird Flu Death Stokes Fears of Another Pandemic. What History Can Teach Us.",
      "url": "https://finnhub.io/api/news?id=beb591990a9d1c4cc9943b7a198492d32cd9d1cefe24a6de7b878113ff645fa6"
    }
  },
  {
    "ts": null,
    "headline": "Arbutus: Positive Imdusiran Data Leads To Phase 2B Development",
    "summary": "Arbutus: Positive Imdusiran Data Leads To Phase 2B Development",
    "url": "https://finnhub.io/api/news?id=9494af34e25e8500c7c49437db21578bbb302d197e5e8d589c04e4a1912e6d7b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736236610,
      "headline": "Arbutus: Positive Imdusiran Data Leads To Phase 2B Development",
      "id": 132299398,
      "image": "",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9494af34e25e8500c7c49437db21578bbb302d197e5e8d589c04e4a1912e6d7b"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: a letter to shareholders reviews 2024",
    "summary": "Moderna has published on its website a letter to shareholders written by its CEO, Stéphane Bancel. In this letter, Moderna announces that the year 2024 was marked by major challenges and notable...",
    "url": "https://finnhub.io/api/news?id=1889b531c5d18a18623e53ef6e219c7d28880b8dbf45168dd65549e1a77c36fa",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736232254,
      "headline": "Moderna: a letter to shareholders reviews 2024",
      "id": 132298461,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna has published on its website a letter to shareholders written by its CEO, Stéphane Bancel. In this letter, Moderna announces that the year 2024 was marked by major challenges and notable...",
      "url": "https://finnhub.io/api/news?id=1889b531c5d18a18623e53ef6e219c7d28880b8dbf45168dd65549e1a77c36fa"
    }
  }
]